MSU
RVPH

Mizuho Securities USA’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Mizuho Securities USA’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-24,287
Closed -$5.17M – 231
2020
Q3 		$5.17M Sell
24,287
-145
-0.6% -$31.2K 0.37% 36
2020
Q2 		$5.2M Sell
24,432
-15,818
-39% -$3.37M 0.35% 40
2020
Q1 		$8.48M Buy
40,250
+8,348
+26% +$1.75M 1.26% 20
2019
Q4 		$6.67M Buy
31,902
+1,902
+6% +$397K 0.33% 29
2019
Q3 		$6.21M Buy
30,000
+1,379
+5% +$284K 0.37% 26
2019
Q2 		$5.88M Buy
28,621
+6,316
+28% +$1.29M 0.27% 26
2019
Q1 		$4.49M Buy
22,305
+6,630
+42% +$1.33M 0.34% 34
2018
Q4 		$3.08M Buy
+15,675
New +$3.07M 0.41% 44

Other funds holding RVPH

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Mizuho Securities USA's RVPH Position: Q4 2020 in Review

Mizuho Securities USA sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q4 2020, closing a stake of 24,287 shares — an estimated $5.17M sold.

Mizuho Securities USA first reported a position in RVPH in Q4 2018 and held it in 8 quarters. The position peaked at $8.48M in Q1 2020. 3 funds tracked by Wall St. Rank hold RVPH as of Q4 2020.

  • Mizuho Securities USA reported no remaining REVIVA PHARMA HLDGS INC position as of Q4 2020 after selling out during the quarter.
  • Mizuho Securities USA sold 24,287 REVIVA PHARMA HLDGS INC shares in Q4 2020, an estimated $5.17M.
  • Mizuho Securities USA first reported a position in REVIVA PHARMA HLDGS INC in Q4 2018 and held it in 8 quarters.
  • Mizuho Securities USA's REVIVA PHARMA HLDGS INC position peaked at $8.48M in Q1 2020.
  • 3 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2020.

Based on Mizuho Securities USA's 13F filing for Q4 2020, filed 29 Jan 2021.